Sherwood Park, Canada

Jacqueline C S Woo

This inventor holds 4 USPTO granted patents. Top assignee: Cytokinetics, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacqueline C S Woo. Retrieved from https://idiyas.com/inventor/jacqueline-c-s-woo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 11.3

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Jacqueline C S Woo

Introduction

Jacqueline C S Woo is a prominent inventor based in Sherwood Park, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 4 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents is the "Salt of omecamtiv mecarbil and process for preparing salt." This patent provides detailed information on omecamtiv mecarbil dihydrochloride salt forms, compositions, and pharmaceutical formulations, along with methods for their preparation and use. This innovation is crucial for advancing therapeutic options in the medical field.

Career Highlights

Jacqueline is currently associated with Cytokinetics, Inc., where she continues to push the boundaries of pharmaceutical research. Her expertise and dedication have played a vital role in the company's innovative projects.

Collaborations

Throughout her career, Jacqueline has collaborated with notable colleagues, including Sheng Cui and Henry Morrison. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Jacqueline C S Woo's contributions to the field of pharmaceuticals through her patents and collaborations highlight her as a key figure in innovation. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…